MMP2 and nonpapillary renal cell carcinoma: As shown in Fig. 8, the above results indicate FAM129A upregulation and/or miR-4521 deficiency contributed FAM129A upregulation affects ccRCC malignancy via the TIMP-1/MMP2/MMP pathway.